Center for biologics evaluation and research (cber) requirement for biologics effectiveness and safety (best) initiative #3: health care data sources for surveillance of biologics (best 3)
Active Awarded Last action
- Contract number
- 75F40124D00042
- Awardee
-
CVS Healthspire Payor & Life Sciences LLC UEI CNYSJ3KBMW97 Part of CVS Health Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Task orders
- 3 $13,839,363 obligated
Award facts
- Opportunity
-
- Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics Pre-Solicitation · 75F40124R00002 · Posted Jun 30, 2024
- Combined order value
- $13,839,363 Current and potential, with all options
- Last date to order 42% complete
- IDV ceiling 18% used
- $75,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 8 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The key products and services being delivered under this federal contract IDV award are data sources and analytics to support the Food and Drug Administration's (FDA) Biologics Effectiveness and Safety (BEST) Initiative. The prime contractor, CVS Healthspire Payor & Life Sciences LLC, a subsidiary of CVS Health Corporation, was awarded a $50 million multiple award IDV to provide healthcare data and conduct safety analyses for the BEST program.
Under a $1.38 million task order, CVS Healthspire is providing the FDA's Center for Biologics Evaluation and Research (CBER) with large-scale, longitudinal healthcare data covering tens of millions of patients, as well as access to full medical charts for patient data review and adjudication. This data will support post-market surveillance of biological drugs under the BEST Initiative #3: Health Care Data Sources for Surveillance of Biologics. The task order is a time and materials contract with a period of performance through September 2025. No set-aside designations were used for this award.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Novation Agreement | $0 | |
| Original award | $10,000 |
Quick answers
Who was awarded contract 75F40124D00042?
75F40124D00042 was awarded to CVS Healthspire Payor & Life Sciences LLC by Food and Drug Administration (Department of Health and Human Services) on September 27, 2024.
How much is contract 75F40124D00042 worth?
Orders under 75F40124D00042 have obligated $13,839,363. 75F40124D00042's own ceiling is $75,000,000.
How many orders have been placed under contract 75F40124D00042?
3 orders have been placed under 75F40124D00042, the latest on September 30, 2026.
Who can order from contract 75F40124D00042?
75F40124D00042 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75F40124D00042 part of a contract vehicle?
Yes. 75F40124D00042 is part of CBER BEST Initiative 3 - Data Sources for Surveillance of Biologics.
Was contract 75F40124D00042 competed?
The extent of competition for 75F40124D00042 was full and open competition. The government received 8 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV